Best of ASCO - 2014 Annual Meeting

 

Welcome

Attend this session at the
2019 ASCO Annual Meeting!


Session: Health Services Research, Clinical Informatics, and Quality of Care

Type: Poster Session

Time: Saturday June 1, 1:15 PM to 4:15 PM

Location: Hall A


Session: Health Services Research, Clinical Informatics, and Quality of Care

Type: Poster Discussion Session

Time: Saturday June 1, 4:30 PM to 6:00 PM

Location: S102

Trends in financial relationships between industry and individual medical oncologists in the United States from 2014 to 2017: A cohort study.

Sub-category:
Value/Cost of Care

Category:
Health Services Research, Clinical Informatics, and Quality of Care

Meeting:
2019 ASCO Annual Meeting

Abstract No:
6520

Poster Board Number:
Poster Discussion Session (Board #211)

Citation:
J Clin Oncol 37, 2019 (suppl; abstr 6520)

Author(s): Deborah Catherine Marshall, Elizabeth Stieglitz Tarras, Kenneth Rosenzweig, Deborah Korenstein, Susan Chimonas; Icahn School of Medicine at Mount Sinai, New York, NY; New York University School of Medicine, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY

Abstract Disclosures

Abstract:

Background: Industry-physician financial relationships in medical oncology are common and introduce conflicts of interest. The Open Payments (OP) program collects and discloses data on industry payments to physicians, in part to discourage inappropriate relationships. However, the effect of OP on how oncologists engage with industry is unknown. Our aim was to evaluate trends in physician-level payments to test whether the implementation of OP has resulted in fewer physicians engaging with industry and has shifted the nature of interactions towards those considered more appropriate. Methods: We performed a retrospective cohort study of US medical oncologists in 2014 from the National Plan and Provider Enumeration System. OP data for general (non-research) payments between 2014-2017 were matched to physician to evaluate receipt of payments over time. We calculated the percentage of physicians receiving payments, annual value and number of payments, and average annual trends over time, including by nature of payment. Results: From 2014-2017, medical oncologists received 1.4 million industry payments totaling $330.6 million. The absolute number of medical oncologists receiving payments decreased 4% on average annually (P= .006), and proportionally from 67.2% to 59.6% overall. The value and number of payments have not significantly changed. The value and number of payments increased for accredited/certified CME (+821% and +209% annually) and decreased for non-accredited/certified CME (-18% and -25% annually). The value and number of food/beverage payments remained the same. The value and number of royalty/licensing payments increased. Conclusions: Fewer oncologists are receiving payments, but spending has not decreased suggesting that physicians are less likely to engage and industry is more selective. Increased payments for accredited CME suggest that less appropriate speaker’s fees are being avoided. Food/beverage payments are not decreasing, thus these interactions may not be recognized as problematic. Increasing royalty/licensing payments require ongoing scrutiny. Changes in physician payments since the inception of OP highlight the importance of transparency in policymaking.

 
Other Abstracts in this Sub-Category:

 

1. Economic analysis of alternative pembrolizumab and nivolumab dosing strategies at an academic cancer center.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6504 First Author: Evan Thomas Hall
Category: Health Services Research, Clinical Informatics, and Quality of Care - Value/Cost of Care

 

2. A process to reduce hospital admissions in the OCM population through focused intervention of super-utilizers.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6505 First Author: Manuel Perry
Category: Health Services Research, Clinical Informatics, and Quality of Care - Value/Cost of Care

 

3. The financial impact of physician practice patterns: An analysis of as-needed filgrastim versus prophylactic pegfilgrastim in patients with prostate cancer receiving docetaxel.

Meeting: 2019 ASCO Annual Meeting Abstract No: 6506 First Author: Christine Barrett
Category: Health Services Research, Clinical Informatics, and Quality of Care - Value/Cost of Care

 

More...